文献速递消化道出血肝病消化内镜

止血粉早期应用于食管胃静脉曲张出血标准管理的随机试验

Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial.
PubMed 文献 · Gut · 2018-05-05

这项随机试验纳入86例肝硬化急性静脉曲张出血患者,比较入院2小时内立即内镜下止血粉喷洒后次日择期内镜与仅择期内镜两种策略。研究组43例中5例需补救内镜,对照组43例中13例需补救内镜(12%vs30%,p=0.034);研究组6周生存率显著改善(7%vs30%,p=0.006)。

要点

  • 止血粉早期应用不依赖高级内镜技术,可在入院2小时内实施。
  • 研究组补救内镜需求低于对照组(12%vs30%,p=0.034)。
  • 研究组6周生存率优于对照组(7%vs30%,p=0.006)。

核心结论

  • 立即应用止血粉的新概念改善了早期临床止血和内镜止血。
  • 这种简化的内镜方法可能对早期和6周生存率产生影响。

研究设计与样本

  • 随机试验,纳入86例急性静脉曲张出血的肝硬化患者,随机分入研究组或对照组各43例。
  • 研究组:入院2小时内立即内镜并喷洒止血粉,次日(入院12-24小时内)行择期内镜确定性治疗。
  • 对照组:仅行早期择期内镜。
  • 两组在择期内镜前未达到临床止血者均接受补救内镜并尝试常规止血。
  • 主要结局为择期内镜时的内镜止血。

主要发现

  • 研究组43例中5例因喷洒止血粉后喷射性出血控制失败(n=4)或早期再出血(1例在重复补救内镜前死亡)需补救内镜。
  • 对照组43例中13例因临床止血失败需补救内镜止血(12%vs30%,p=0.034)。
  • 研究组其余38例在择期内镜时均实现内镜止血。
  • 对照组其余30例在择期内镜时均有新鲜胃内血液或喷射性出血(10%),但均成功止血。
  • 研究组6周生存率显著改善(7%vs30%,p=0.006)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute variceal bleeding (AVB) requires early therapeutic management by experienced endoscopists that often poses logistical challenges for hospitals. We assessed a different management concept with early application of haemostatic powder-which does not require high endoscopic expertise-added to conventional management in a randomised trial. METHODS: Cirrhotic patients with AVB received standard medical therapy and were randomised to either immediate endoscopy with haemostatic powder application within 2 hours of admission, followed by early elective endoscopy on the next day, that is, within 12-24 hours of admission for definitive treatment (study group) or to early elective endoscopy only (control group). In both groups, failures to achieve clinical haemostasis until the time of early elective endoscopy underwent rescue endoscopy with attempted conventional haemostasis. Primary outcome was endoscopic haemostasis at the elective endoscopy. RESULTS: Of 86 randomised patients with AVB, 5/43 in the study group required rescue endoscopy for failure of controlling spurting bleeding (n=4) after powder application or for early bleeding recurrence in one patient who died before repeating rescue endoscopy. In the control group, 13/43 patients required rescue endoscopic haemostasis for failure of clinical haemostasis (12%vs30%, p=0.034). In the remaining patients, early elective endoscopic haemostasis was achieved in all 38 patients in the study group, while all remaining 30 patients in the control group had fresh gastric blood or (10%) spurting bleeding at early elective endoscopy with successful haemostasis in all of them. Six-week survival was significantly improved in the study group (7%vs30%, p=0.006). CONCLUSION: The new concept of immediate powder application improves early clinical and endoscopic haemostasis. This simplified endoscopic approach may have an impact on early and 6-week survival. TRIAL REGISTRATION NUMBER: NCT03061604.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ibrahim M, El-Mikkawy A, Abdel Hamid M, et al. Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial. Gut. 2018. PMID: 29730601. doi:10.1136/gutjnl-2017-314653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。